Women’s Health

Women everywhere deserve accessible, affordable and comprehensive healthcare. This includes reproductive healthcare like contraception, abortion, sex and relationship education, STI prevention and treatment, cancer screenings and counseling. However, lawmakers have long attempted to restrict or reduce this care in ways that harm women.

War on Women Report: Meta Removes Abortion-Related Accounts; Louisiana Tries to Extradite California Abortion Provider; Fatal ICE Shootings

PUBLISHED 1/30/2026 by

MAGA Republicans are back in the White House, and Project 2025 is their guide—the right-wing plan to turn back the clock on women’s rights, remove abortion access, and force women into roles as wives and mothers in the “ideal, natural family structure.” We know an empowered female electorate is essential to democracy. That’s why day after day, we stay vigilant in our goals to dismantle patriarchy at every turn. We are watching, and we refuse to go back. This is the War on Women Report.

Since our last report:
—Kentucky Attorney General Russell Coleman has tried to remove pro-abortion ads from Mayday Health, an organization that shares information about abortion pills, birth control and gender-affirming care.
—The FDA withdrew a rule requiring cosmetics companies to test their products made with talc for asbestos, alarming public health advocates.
—Two Pennsylvania hospitals told the state they may not provide emergency contraception to sexual assault survivors because of religious objections.
—Some good news out of Wyoming: The state’s supreme court started the new year by striking down Wyoming’s two abortion bans.

… and more.

Women Are Being Priced Out of Health Coverage—and Congress Knows It

PUBLISHED 1/21/2026 by

With the 2026 Affordable Care Act (ACA) open enrollment period now closed, millions of Americans are facing an uncomfortable new reality: higher monthly costs for the health coverage they already struggled to afford.

When health insurance becomes unaffordable, women don’t just absorb the cost. They make sacrifices—often at the expense of their health. They end up skipping preventive services, delaying medical tests, forgoing mental healthcare, and leaving prescriptions unfilled. The consequences can be severe: delayed diagnoses, worsened health outcomes, poorer quality of life, and higher costs down the road for families and the health system.

Unable to wait for Congress to act to extend the credits, the vast majority of Americans have already made their health insurance decisions for 2026. With the enrollment deadline passed, women have had to make decisions based on what they can afford right now—not on promises that may never materialize.

One Year In: 53 Ways the Second Trump Administration Is Harming Women and Families

PUBLISHED 1/20/2026 by

A sweeping, year-one rundown of how Trump’s second-term power grabs and policy rollbacks are eroding women’s rights, healthcare and economic security, including—from dismantling the Women’s Bureau at the Department of Labor and shuttering reproductive health clinics, to passing historic cuts to the Medicaid program and sowing mistrust in abortion pill safety.

‘The Moral Property of Women’: Mifepristone, Fibroids and the Stakes of Suppressed Science

PUBLISHED 1/20/2026 by

Despite mifepristone’s broad medical promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access.

More than 26 million women in the U.S. are affected by fibroids, which are noncancerous growths of the uterus that can reach the size of a grapefruit or larger. Treatment too often defaults to invasive surgery, either removing the fibroids or performing hysterectomies.

In China today, a three-month regimen of 10 milligrams of mifepristone per day is the approved protocol for treating fibroids. Meanwhile, American women still do not have access to this very effective nonsurgical treatment.

This is Part 1 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

Seven Ways the Trump Administration Has Made Pregnancy More Dangerous

PUBLISHED 1/8/2026 by

Trump has been in office for less than a year. The Supreme Court killed Roe v. Wade less than three years ago. And today, if you are a woman in the United States, your rights change when you cross state lines—men’s rights do not. 

It’s easy to lose sight of just how debilitating this administration has been for reproductive rights, because they are doing so much else so loudly. (Apologies to Greenland.) But this administration has quietly attacked abortion rights from just about every angle. A new report from the Center for Reproductive Rights makes clear just how aggressive they’ve been. 

Here are seven quiet moves from the Trump administration that are costing women and girls their lives.

Ms. Global: Iraq’s Child Marriage Surge, Hurricane Devastation in Jamaica, Historic EU Abortion Vote and More

PUBLISHED 1/7/2026 by and

The U.S. ranks as the 19th most dangerous country for women, 11th in maternal mortality, 30th in closing the gender pay gap, 75th in women’s political representation, and painfully lacks paid family leave and equal access to health care. But Ms. has always understood: Feminist movements around the world hold answers to some of the U.S.’s most intractable problems. Ms. Global is taking note of feminists worldwide.

This week: News from Iraq, Jamaica, the EU, Cambodia and Thailand, and more.

What’s Next for Menopause Legislation in Your State?

PUBLISHED 1/7/2026 by

An unprecedented 19 states have introduced three dozen bills to improve menopause care and treatment; eight of those bills are now law.

At the federal level, the U.S. Food and Drug Administration finally removed the “black box warning” on estrogen products, ushering in a new era for menopause care whereby women and their doctors can make decisions without the unnecessary fear the prior label engendered.

And so, we kick off the new year with a mighty impressive track record. Can we expect more of the same in 2026? My prediction is a resounding yes. This is only the beginning of a long overdue and much deeper series of demands. Here’s my forecast for what to expect in the weeks and months ahead.

RFK Jr. Wants to Scrutinize the Vaccine Schedule—But its Safety Record Is Already Decades Long

PUBLISHED 1/5/2026 by

The U.S. childhood immunization schedule, the grid of colored bars pediatricians share with parents, recommends a set of vaccines given from birth through adolescence to prevent a range of serious infections. The basic structure has been in place since 1995, when federal health officials and medical organizations first issued a unified national standard, though new vaccines have been added regularly as science advanced.

Vaccines on the childhood schedule have been tested in controlled trials involving millions of participants, and they are continuously monitored for safety after being rolled out. The schedule represents the accumulated knowledge of decades of research. It has made the diseases it targets so rare that many parents have never seen them.

But the schedule is now under scrutiny.

What the ‘Wicked’ Weight-Loss Discourse Gets Wrong

PUBLISHED 12/17/2025 by

We can’t afford to look away from changing beauty norms in our society, and how they are fueling eating disorders. 

Jennifer Rollin, an eating disorder therapist based in Maryland, says, “What I hear from a lot of clients is that when they are trying to recover from their eating disorder in this society, it almost feels wrong, because ‘everyone around me is talking about Ozempic,’ and ‘all the celebrities are talking about their big amount of weight loss.’”

But while it can feel cathartic to criticize or distance ourselves from prominent women who seem to be conforming to dangerous beauty standards, that criticism is harmful and does not bring us any closer to addressing the problem.

This FDA Decision Could Transform Menopause Care

PUBLISHED 11/12/2025 by and

On Monday, Nov. 10, the U.S. Department of Health and Human Services announced that the Food and Drug Administration would eliminate the “boxed labeling” requirement for estrogen products.

The “black box warning,” as it’s commonly called, is part of the fallout from a press conference that occurred more than 20 years ago, announcing the findings of the Women’s Health Initiative (WHI). It’s also been the subject of a half-century-long push and pull with the federal government.

Make no mistake, this has been a longstanding demand—it’s neither new nor MAHA-driven. Doctors and scientists have made the case for its removal since the start to no avail, arguing the data from the WHI—the largest, most expensive, and only randomized placebo-controlled study of post-menopausal women—never supported putting it there in the first place.

The FDA’s reversal of the labeling requirement is a major win for evidence-based medicine. Now it’s up to us to responsibly inform women of their choices.